EXPAND AND CONSOLIDATE GLOBAL FOOTPRINT

to provide access to quality medicines at an affordable price

Konw More

About IMSDA

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

In The News

CDSCO Adopts Risk-Based Drug Regulation Framework in India - The Central Drugs Standard Control Organisation (CDSCO) has signalled a major shift in India’s drug regulatory framework, moving toward a risk-based approach designed to reduce compliance burdens for pharmaceutical manufacturers while strengthening oversight of high-risk products. The announcement, made in early September 2026, has drawn attention from industry stakeholders ahead of the iPHEX 2026 expo. […]
Piyush Goyal Urges Indian Pharma to Move Beyond Generics into High-Value Medicines - 🔬 The Bigger Picture: India’s Pharma Ambition Minister Goyal’s remarks at the Bharat Health Global Expo 2026 fit within a broader pattern of government statements throughout 2026 emphasizing India’s ambition to become a comprehensive global pharmaceutical powerhouse — not just a generic drug supplier. Earlier in the year, the Minister stated that India’s pharma sector […]
CDSCO Moves to Ban Same Brand, Different Drug Practice in India - What This Means for Generic Medicine Buyers For international buyers and procurement professionals sourcing generic medicines from India, this regulatory direction has several practical implications: Brand-name reliance is decreasing as a safe procurement strategy. Buyers who source by brand name alone should now factor in that CDSCO is actively working to restrict how brand names […]
iPHEX 2026: 600+ Global Delegates Set to Source from India’s Pharma Sector - What This Means for Buyers of Indian Generic Medicines For healthcare procurement professionals, distributors, and pharmacy chain buyers, iPHEX 2026 represents a concentrated opportunity to: Evaluate multiple Indian generic medicine suppliers in a single venue Discuss WHO-GMP and CDSCO compliance documentation directly with manufacturers Explore pricing structures for high-volume generic categories including cardiovascular, diabetes, and […]
Read More

Our Videos

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Konw More

Stay Connected

If you have any question,please connect us.

Connect Us

Join Us

The India Medicine Sales & Distribution Association ( IMSDA ) represents 24 leading research-based Indian pharmaceutical companies. IMSDA plays the role of a catalyst role in shaping policy framework to unlock and unleash the potential of the Indian pharmaceutical industry in line with the national priorities

Join Us